Back stories on ghostwriting here.
Frederic Curtiss is editor-in-chief of the Journal of Managed Care Pharmacy.
In what is probably a first for the journal, the June issue featured an article where a medical writer shares authorship with a scientist. "Much to their consternation, we listed an author who did not want to be listed," Curtiss says.
The article was on the Eli Lilly and Company drug Effient (Prasugrel) for preventing atherothrombosis and was prepared with financial support from the pharmaceutical company.
The published version of the article lists Sarah Spinler of the University of the Sciences in Philadelphia and Catherine Rees, a senior medical writer for Adis Communications.
According to the published disclosure statement, "Rees performed the majority of data collection and writing of the initial draft, and both authors shared equally in the revision."
However, Curtiss says Rees did not wish to be a co-author.
He would not say how he learned of Rees's involvement in the manuscript and whether it was disclosed upon submission.
Rees, who is based in Auckland, New Zealand, and is a member of the Australasian Medical Writers Association, confirmed over the telephone that she was not initially listed as an author on the paper but declined to answer any further questions.
No comments:
Post a Comment